Cancer drugs

Cancer drugs

Drugs, agents used in the treatment of cancer or conditions related to cancer.

Contributors in Cancer drugs

Cancer drugs

A radioactive isotope of iodine, a nonmetallic element of the halogen group. With a half-life of 60 days, iodine 125 occurs naturally and can be produced artificially. This agent has both therapeutic ...

cesium Cs 137

Pharmaceutical; Cancer drugs

A radioactive isotope of cesium with an atomic mass of 139 and potential application in radiotherapy. Cesium Cs 137 is prevalent due to its spontaneous production, which occurs as a result of nuclear ...

iodine I 123

Pharmaceutical; Cancer drugs

A radioactive isotope of iodine, a nonmetallic element of the halogen group with an atomic mass of 123 and a half-life of 13. 2 hours with radioisotopic activity. Selectively accumulating in the ...

alpha-lipoic acid analogue CPI-613

Pharmaceutical; Cancer drugs

A racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential chemopreventive and antineoplastic activities. Although the exact mechanism of action is unknown, ...

p53 activator APR-246

Pharmaceutical; Cancer drugs

A quinuclidinone derivative that targets the p53 protein with potential antineoplastic activity. The p53 activator APR-246 refolds/reactivates the p53 protein, which may lead to an induction of cell ...

semaxanib

Pharmaceutical; Cancer drugs

A quinolone derivative with potential antineoplastic activity. Semaxanib reversibly inhibits ATP binding to the tyrosine kinase domain of vascular endothelial growth factor receptor 2 (VEGFR2), which ...

tasquinimod

Pharmaceutical; Cancer drugs

A quinoline-3-carboxamide linomide analogue with antiangiogenic and potential antineoplastic activities. Tasquinimod has been shown to decrease blood vessel density but the exact mechanism of action ...